Hepatocellular Carcinoma Clinical Trials in Bologna
8 recruitingBologna, Italy
Showing 1–8 of 8 trials
Recruiting
Phase 1
Study of Zanzalintinib in Combination With Immuno-Oncology Agents in Participants With Solid Tumors
Head and Neck Squamous Cell Carcinoma (HNSCC)Non-small Cell Lung Cancer (NSCLC)Solid Tumor+7 more
Exelixis1,314 enrolled122 locationsNCT05176483
Recruiting
Phase 1
A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors
Gastric CancerEndometrial CancerHepatocellular Carcinoma+5 more
Seagen, a wholly owned subsidiary of Pfizer714 enrolled61 locationsNCT05208762
Recruiting
Phase 3
Phase III Study of Rilvegostomig in Combination With Bevacizumab With or Without Tremelimumab as First-line Treatment of Hepatocellular Carcinoma
Hepatocellular Carcinoma
AstraZeneca1,220 enrolled204 locationsNCT06921785
Recruiting
Phase 2Phase 3
A Study to Assess the Dose, Adverse Events, and Change in Disease Activity of Livmoniplimab as an Intravenous (IV) Solution in Combination With Budigalimab as an IV Solution in Adult Participants With Hepatocellular Carcinoma (HCC)
Hepatocellular Carcinoma
AbbVie660 enrolled37 locationsNCT06109272
Recruiting
Sarcopenia and Systemic Therapy in HCC
HCC - Hepatocellular Carcinoma
IRCCS Azienda Ospedaliero-Universitaria di Bologna270 enrolled1 locationNCT06805552
Recruiting
Can Hepatic-splenic Elastography Predict the Risk of Hepatocellular Recurrence After Radiofrequency Ablation?
HCC - Hepatocellular Carcinoma
IRCCS Azienda Ospedaliero-Universitaria di Bologna50 enrolled1 locationNCT06777017
Recruiting
Intra Artherial Therapies in Treatment of Primary Liver Diseases: an Observational Study
HCC - Hepatocellular CarcinomaCholangiocarcinoma Cancer
IRCCS Azienda Ospedaliero-Universitaria di Bologna3,300 enrolled1 locationNCT06774690
Recruiting
Phase 3
The ABC-HCC Trial: Atezolizumab Plus Bevacizumab vs. Transarterial Chemoembolization (TACE) in Intermediate-stage HepatoCellular Carcinoma
Hepatocellular Carcinoma
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest434 enrolled72 locationsNCT04803994